Relief Therapeutics Holding AG (RLFTF)

[tcm55]

Ah yes, The 'JEWEL'
" Its lead drug candidate RLF-100TM (aviptadil) is being investigated in two placebo-controlled U.S. late-stage clinical trials in respiratory deficiency due to COVID-19. Relief holds a patent issued in the United States and various other countries covering potential formulations of RLF-100TM.

NeuroRx is solely responsible for clinical development and regulatory submissions related to RLF-100™ in the U.S."

...GLTA...